Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children

Gili Regev-Yochay1, Ron Dagan, Meir Raz

  • 1Sheba Medical Center, Tel Hashomer, Israel. gili.regev@sheba.health.gov.il

JAMA
|August 12, 2004
PubMed

Insights

Streptococcus pneumoniae carriage is inversely linked to Staphylococcus aureus carriage in children. This interaction is important for understanding respiratory tract flora changes, especially with pneumococcal conjugate vaccination.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Epidemiology

Background:

  • Pneumococcal conjugate vaccination may alter upper respiratory tract flora in children.
  • Emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) highlights potential interactions with Streptococcus pneumoniae.

Purpose of the Study:

  • To determine the prevalence and risk factors for Streptococcus pneumoniae and Staphylococcus aureus carriage in young children before widespread vaccination.
  • To investigate the relationship between carriage of these two common respiratory pathogens.

Main Methods:

  • Cross-sectional surveillance study conducted in primary care clinics in central Israel.
  • Nasopharyngeal and nasal swabs collected from 790 children aged 40 months or younger.
  • Analysis of carriage rates, serotypes for S. pneumoniae, and associated risk factors for both pathogens.

Main Results:

  • Prevalence: 43% carried S. pneumoniae, 10% carried S. aureus.
  • Inverse Association: S. pneumoniae carriage was lower in S. aureus carriers (27.5% vs 44.8%). S. aureus carriage was lower in S. pneumoniae carriers (6.5% vs 12.9%).
  • Dual Carriage: Only 2.8% carried both pathogens, which was less than the expected 4.3% (P=.03). Risk factors for S. pneumoniae carriage were negatively associated with S. aureus carriage.

Conclusions:

  • Streptococcus pneumoniae carriage, particularly vaccine-type strains, is negatively associated with Staphylococcus aureus carriage in children.
  • These findings suggest a complex interaction between these pathogens that warrants further investigation in the context of pneumococcal vaccination programs.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...